March 18, 2021 12:13 PM EDTUpdated 02:29 PM
FDA+
Coronavirus

EMA calls for As­traZeneca vac­ci­na­tions to con­tin­ue af­ter safe­ty scares de­layed roll­out

Zachary Brennan

Senior Editor

The Eu­ro­pean Med­i­cines Agency (EMA) said Thurs­day that the use of As­traZeneca’s vac­cine should con­tin­ue as new de­tails emerge of some of the cas­es that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times